Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease

This publication has 29 references indexed in Scilit:

• Levels of circulating collagenase, stromelysin‐1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis: relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation
  Arthritis & Rheumatism, 1995
• Serum collagenase activity in patients with chronic liver disease
  Journal of Hepatology, 1993
• Synthesis of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in human hepatoma cells (HepG2) Up‐regulation by interleukin‐6 and transforming growth factor β1
  FEBS Letters, 1992
• Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.
  Journal of Clinical Investigation, 1992
• Increased transforming growth factor-β1 gene expression in human liver disease
  Journal of Hepatology, 1992
• Transforming Growth Factors β1 and α in Chronic Liver Disease
  New England Journal of Medicine, 1991
• Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.
  Journal of Clinical Investigation, 1989
• High Metalloproteinase Inhibitor Content of Human Cirrhosis and Its Possible Conference of Metastasis Resistance2
  JNCI Journal of the National Cancer Institute, 1988
• Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis
  Life Sciences, 1982
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
  Hepatology, 1981